Epigenetic Inhibitors: Discovery to Clinic - A Medicinal Chemist's Perspective
with Dr. Matthew Fuchter, Senior Lecturer of Synthetic and Medicinal Chemistry at the Imperial College London. NEW!
The Future of Fragments and PPIs
with Daniel A. Erlanson, Ph.D., Co-Founder, Carmot Therapeutics, Inc. and Edward R. Zartler, Ph.D., President & CSO, Quantum Tessera Consulting NEW!
View All Sponsors
View Attendee List
View Media Partners
Download 2016 Final Agenda
Training Seminar | Friday, April 22
Short Courses | Monday, April 18
Short Courses | Wednesday, April 20